$Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction$

Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction

Background: Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden cardiac death among patients with persistently reduced (≤35 %) left ventricular ejection fraction (LVEF) at least 40 days following acute myocardial infarction (AMI). Few prior studies have used LVEF measured after...

Full description

Bibliographic Details
Main Authors:	Gregory L. Judson, Beth E. Cohen, Anoop Muniyappa, Merritt H. Raitt, Hui Shen, Gary Tarasovsky, Mary A. Whooley, Sanket S. Dhruva
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	American Heart Journal Plus
Subjects:	Implantable cardioverter-defibrillators Guideline-based care Cardiovascular disease among Veterans Myocardial infarction
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666602222001033

Similar Items

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

Implantable cardioverter-defibrillators step by step : an illustrated guide /
by: 439461 Stroobandt, Roland X., et al.
Published: (2009)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Implantable Cardioverter Defibrillator Stored ECGs [electronic resource]: Clinical Management and Case Reports/
by: 410467 Jordaens, Luc J., et al.
Published: (2007)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
by: Johanna Mueller‐Leisse, et al.
Published: (2021-12-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
by: Daniel B. Kramer, et al.
Published: (2015-05-01)

Adaptation status and related factors in patients living with implantable cardioverter defibrillators
by: Mohammadreza Razavi, et al.
Published: (2022-01-01)

An unusual cause of recurrent syncope in a patient with implantable cardioverter defibrillator
by: Armando Gardini, et al.
Published: (2015-07-01)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
by: Marc Strik, et al.
Published: (2023-10-01)

Stent and implantable cardioverter defibrillator implantation in medically resistant vasospastic angina patient
by: Nil Özyüncü, et al.
Published: (2017-10-01)

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
by: Joshi Subodh B, et al.
Published: (2012-10-01)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01)

Interval training effects in patients with implantable cardioverter defibrillator depending on their exercise tolerance level
by: Kamila Bielecka-Kowal, et al.
Published: (2020-03-01)

Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants
by: Javad Shahabi, et al.
Published: (2024-08-01)

The contribution of implantable cardioverter defibrillators to systemic inflammation in heart failure patients
by: Ozcan Orscelik, et al.
Published: (2019-06-01)

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)

Magnetic Resonance Assessment of Ejection Fraction Versus Echocardiography for Cardioverter-Defibrillator Implantation Eligibility
by: Călin Schiau, et al.
Published: (2021-10-01)

“Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database
by: Diogo de Almeida Fernandes, et al.
Published: (2023-12-01)

Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)

Multicenter prospective observational study to clarify the current status and clinical outcome in Japanese patients who have an indication for implantable cardioverter defibrillator (ICD) or wearable cardioverter defibrillator (WCD) (TRANSITION JAPAN‐ICD/WCD study): Rationale and design of a prospective, multicenter, observational, comparative study
by: Yukitoshi Ikeya, et al.
Published: (2024-06-01)

Long-term clinical outcomes in implantable cardioverter defibrillator recipients on the island of Crete
by: Emmanuel M. Kanoupakis, et al.
Published: (2016-07-01)

Current status of wearable cardioverter‐defibrillator use in Japan
by: Reina Tonegawa‐Kuji, et al.
Published: (2024-08-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Air entrapment causing ventricular oversensing early after implantation of an extravascular implantable cardioverter-defibrillator
by: Julia Hermes, MD, et al.
Published: (2024-09-01)

Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
by: Begisbayev T, et al.
Published: (2022-10-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)